3Esposito M,Grusovin MG,Worthington HV.Treatment of peri-implantitis:what interventions are effective?A Cochrane systematic review[J].Eur J Oral Implantol,2012,5(Suppl):S21-41.
4Hilton TJ,Ferracane JL,Mancl L,et al.Comparison of CaO H with MTA for direct pulp capping:a PBRN randomized clinical trial[J].J Dent Res,2013,92(7 Suppl):16S-22S.
5Torabinejad M,Parirokh M.Mineral trioxide aggregate:a comprehensive literature review-part II:leakage and biocompatibility investigations[J].J Endod,2010,36(2):190-202.
6Torabinejad M,Hong CU,McD onald F,et al.Physical and chemical properties of a new root-end filling material[J].J Endod,1995,21(7):349-353.
7Sasan MJ,Maria GM,Tatiana MB,et al.Effect of ProRoot MTA on pulp cell apoptosis and proliferation in vitro[J].JOE,2005,31(3):387-391.
8Aeinehchi M,Eslami B,Ghanbariha M,et al.Mineral trioxide aggregate(MTA)and calcium hydroxide as pulp-capping agents in human teeth:a preliminary report[J].Int Endod J,2003,36(3):225-231.
